297 related articles for article (PubMed ID: 28287407)
1. Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling.
Ansa-Addo EA; Zhang Y; Yang Y; Hussey GS; Howley BV; Salem M; Riesenberg B; Sun S; Rockey DC; Karvar S; Howe PH; Liu B; Li Z
J Clin Invest; 2017 Apr; 127(4):1321-1337. PubMed ID: 28287407
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
[TBL] [Abstract][Full Text] [Related]
3. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
[TBL] [Abstract][Full Text] [Related]
4. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
[TBL] [Abstract][Full Text] [Related]
5. Dlg5 interacts with the TGF-β receptor and promotes its degradation.
Sezaki T; Tomiyama L; Kimura Y; Ueda K; Kioka N
FEBS Lett; 2013 Jun; 587(11):1624-9. PubMed ID: 23624079
[TBL] [Abstract][Full Text] [Related]
6. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
[TBL] [Abstract][Full Text] [Related]
7. The ERM Protein Moesin Regulates CD8
Satooka H; Nagakubo D; Sato T; Hirata T
J Immunol; 2017 Nov; 199(10):3418-3426. PubMed ID: 28978692
[TBL] [Abstract][Full Text] [Related]
8. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
Deng X; Bellis S; Yan Z; Friedman E
Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
[TBL] [Abstract][Full Text] [Related]
9. TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.
Kim YW; Park J; Lee HJ; Lee SY; Kim SJ
Biochem J; 2012 Aug; 445(3):403-11. PubMed ID: 22571197
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.
Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K
J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687
[TBL] [Abstract][Full Text] [Related]
11. TMED10 Protein Interferes with Transforming Growth Factor (TGF)-β Signaling by Disrupting TGF-β Receptor Complex Formation.
Nakano N; Tsuchiya Y; Kako K; Umezaki K; Sano K; Ikeno S; Otsuka E; Shigeta M; Nakagawa A; Sakata N; Itoh F; Nakano Y; Iemura SI; van Dinther M; Natsume T; Ten Dijke P; Itoh S
J Biol Chem; 2017 Mar; 292(10):4099-4112. PubMed ID: 28115518
[TBL] [Abstract][Full Text] [Related]
12. Menin expression is regulated by transforming growth factor beta signaling in leukemia cells.
Zhang H; Liu ZG; Hua XX
Chin Med J (Engl); 2011 May; 124(10):1556-62. PubMed ID: 21740816
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.
Takahashi E; Nagano O; Ishimoto T; Yae T; Suzuki Y; Shinoda T; Nakamura S; Niwa S; Ikeda S; Koga H; Tanihara H; Saya H
J Biol Chem; 2010 Feb; 285(6):4060-4073. PubMed ID: 19965872
[TBL] [Abstract][Full Text] [Related]
14. Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors.
Tu K; Li J; Verma VK; Liu C; Billadeau DD; Lamprecht G; Xiang X; Guo L; Dhanasekaran R; Roberts LR; Shah VH; Kang N
Hepatology; 2015 Jan; 61(1):361-74. PubMed ID: 24917558
[TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses.
Konkel JE; Zhang D; Zanvit P; Chia C; Zangarle-Murray T; Jin W; Wang S; Chen W
Immunity; 2017 Apr; 46(4):660-674. PubMed ID: 28423340
[TBL] [Abstract][Full Text] [Related]
16. IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.
Liu C; Billadeau DD; Abdelhakim H; Leof E; Kaibuchi K; Bernabeu C; Bloom GS; Yang L; Boardman L; Shah VH; Kang N
J Clin Invest; 2013 Mar; 123(3):1138-56. PubMed ID: 23454766
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
18. AKT hyperactivation confers a Th1 phenotype in thymic Treg cells deficient in TGF-β receptor II signaling.
Liu Y; Xu Y; Sun J; Ma A; Zhang F; Xia S; Xu G; Liu Y
Eur J Immunol; 2014 Feb; 44(2):521-32. PubMed ID: 24165986
[TBL] [Abstract][Full Text] [Related]
19. Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
Fernandez T; Amoroso S; Sharpe S; Jones GM; Bliskovski V; Kovalchuk A; Wakefield LM; Kim SJ; Potter M; Letterio JJ
J Exp Med; 2002 May; 195(10):1247-55. PubMed ID: 12021305
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.
Tarakanova VL; Wold WS
J Virol; 2003 Sep; 77(17):9324-36. PubMed ID: 12915548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
